真武汤合葶苈大枣泻肺汤联合西药治疗阳虚 水泛证慢性阻塞性肺疾病的临床观察
2025-08-10王秋林



Clinical Observation on the Treatment of Chronic Obstructive Pulmonary Disease with Yang Deficiency and Water Flooding Syndrome by Combining Zhenwu Decoction and Tingli Dazao Xiefei Decoction withWesternMedicine/WANGQiulin.//Medical Innovationof China,2025,22(20): 024-028
[Abstract] Objective:To analyze the effect of Zhenwu Decoction and Tingli Dazao Xiefei Decoction combined with western medicine in the treatment of chronic obstructive pulmonary disease (COPD) patients with Yangdeficiency and water flooding syndrome.Method:A total of1O4 COPD patients with Yang deficiencyand water flooding syndrome wereadmited to Xiamen Hospitalof T.C.M from December 2O22 to December 2024.They were randomly divided into two groups,with 52 patients ineach group,using arandom number table method.The control group was treated with western medicine,while the observation group was aditionally treated with Zhenwu Decoction and Tingli Dazao Xiefei Decoction.The therapeutic effcts of two groups were compared.Result: The total effective rate of the observation group was 96.15% (50/52),which was higher than the control group's 84.62% (20 (44/52),the difference was statisticallysignificant ( P lt;0.05).After2 weeks of treatment,the coughwheezing inability to lie down,sparse sputum,chest and diaphragm tightness,dark purple ontheface and lips,palpitations,chills,and reduced urine output scores of the observation group were ( 1.58±0.16) , (1.44±0.17) ,( 1.36±0.16 , (0.71±0.10) 0 0.64±0.08 ) 0.63±0.05) (, 0.81±0.09 )points,respectively, PaCO2 was (41.42±3.21 ) mmHg,and the IL-6, CRP, procalcitonin,and TNF- α were
, (8.33±1.29)mg/L , (0.12±0.01 ) μg/L ,and 4.59±0.63 ) μg/L , which were all lower than the control group's ( 2.63±0.24) ! (2.36±0.20) (2.48±0.27) , 1.24±0.18 , (1.35±0.12) , (1.19±0.12) , (1.42±0.18) points,and
and ( 6.35±1.05 ) μg/L ,respectively; the Pa02 was (80.69±8.44 )mmHg,higher than the control group's (2 (71.59±7.35) mmHg; the 6-minute walking test (6MWT) distance was (435.98±48.64)m ,longer than the control group's (369.82±40.59) m; there were statistically significant differences in the above indicators (Plt;0.05) . There was no significant difference in adverse reactions between the two groups' (Pgt;0.05) . Conclusion: Zhenwu Decoction and Tingli Dazao Xiefei Decoction combined with western medicine can regulate blood gas indicators,reduce inflammation,improve exercise endurance,and is safe and feasible for COPD patients with Yang deficiency and water flooding syndrome.
[KeyWords]Chronic obstructive pulmonary disease Zhenwu Decoction and Tingli Dazao Xiefei Decoction Yang deficiency and water floodingBlood gas indicatorsExercise enduranceAdverse reactions
First-author'saddress:Department ofRespiratory and Critical Care Medicine,Xiamen Hospital ol T.C.M,Xiamen 361000, China
doi:10.3969/j.issn.1674-4985.2025.20.006
慢性阻塞性肺疾病(COPD)是多发的肺部病症,中老年人群为该病的高发群体[]。近年,因老龄化加速等因素的影响,COPD的患病率呈逐年升高趋势[2]。COPD患者有呼吸困难、咳嗽等症状,病程持续时间长,且容易反复发作,给患者的身心健康造成较多危害[3-4]。西医常采用扩张气管、抗感染等综合治疗,但仍有少数患者在停药之后病情会复发,远期效果不佳[5。中医将该病归为“肺胀”或“喘病”范畴,病机为本虚标实,辨证多为阳虚水泛证,多因肺、脾、肾阳气亏虚,津液输布功能紊乱,水湿内停于肺,最终发为本病,在治疗上需注重宣肺平喘、温阳化饮原则。真武汤为中药汤剂,可发挥利水消肿、温补肾阳等效果。葶苈大枣泻肺汤则能发挥止咳化痰、清肺降逆效用。基于此,本研究以2022年12月—2024年12月厦门市中医院收治的104例阳虚水泛证COPD患者为研究对象,分析中西医联合的具体效果,报道如下。
1资料与方法
1.1一般资料
选取2022年12月—2024年12月本院收治的104例阳虚水泛证COPD患者。纳入标准:西医符合文献[7]《慢性阻塞性肺疾病基层诊疗指南(2018年)》诊断;中医符合文献[8]《慢性阻塞性肺疾病中医诊疗指南(2011版)》诊断;无药物过敏史;认知清晰能正常交流;有正常读写能力。排除标准:孕妇;存在严重感染;既往有肺部手术史;伴有其他肺部病症;合并恶性肿瘤。按随机数字表法分为两组,各52例,本研究经厦门市中医院医学伦理委员会批准,且患者及家属对本研究知情。
1.2方法
对照组行西药治疗。采用布地奈德福莫特罗吸人粉雾剂(II)(AstraZenecaAB,国药准字H20160447,60吸/支,每吸含布地奈德 320μg 和富马酸福莫特罗 9.0μg ),1吸/次,2次/d;……
